BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 28412366)

  • 1. NANOG gene expression is regulated by the ETS transcription factor ETV4 in human embryonic carcinoma NCCIT cells.
    Park SW; Do HJ; Choi W; Song H; Chung HJ; Kim JH
    Biochem Biophys Res Commun; 2017 Jun; 487(3):532-538. PubMed ID: 28412366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelium-specific ETS transcription factor-1 regulates NANOG expression and inhibits NANOG-induced proliferation of human embryonic carcinoma cells.
    Park SW; Do HJ; Choi W; Lim DS; Park KH; Kim JH
    Biochimie; 2021 Jul; 186():33-42. PubMed ID: 33865902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional regulation of OCT4 by the ETS transcription factor ESE-1 in NCCIT human embryonic carcinoma cells.
    Park SW; Do HJ; Ha WT; Han MH; Yang HM; Lee SH; Song H; Kim NH; Kim JH
    Biochem Biophys Res Commun; 2014 Jul; 450(2):984-90. PubMed ID: 24971534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depletion of embryonic stem cell signature by histone deacetylase inhibitor in NCCIT cells: involvement of Nanog suppression.
    You JS; Kang JK; Seo DW; Park JH; Park JW; Lee JC; Jeon YJ; Cho EJ; Han JW
    Cancer Res; 2009 Jul; 69(14):5716-25. PubMed ID: 19567677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of ETV4 at Ser73 by ERK kinase could block ETV4 ubiquitination degradation in colorectal cancer.
    Xiao J; Yang S; Shen P; Wang Y; Sun H; Ji F; Zhou D
    Biochem Biophys Res Commun; 2017 May; 486(4):1062-1068. PubMed ID: 28373072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of human growth and differentiation factor 3 gene expression by NANOG in human embryonic carcinoma NCCIT cells.
    Park SW; Lim HY; Do HJ; Sung B; Huh SH; Uhm SJ; Song H; Chung HJ; Kim JH; Kim NH; Kim JH
    FEBS Lett; 2012 Sep; 586(19):3529-35. PubMed ID: 22963770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXC1 Downregulates Nanog Expression by Recruiting HDAC2 to Its Promoter in F9 Cells Treated by Retinoic Acid.
    Xue H; Liu F; Ai Z; Ke J; Yu M; Chen B; Guo Z
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ETV4 Facilitates Cell-Cycle Progression in Pancreatic Cells through Transcriptional Regulation of Cyclin D1.
    Tyagi N; Deshmukh SK; Srivastava SK; Azim S; Ahmad A; Al-Ghadhban A; Singh AP; Carter JE; Wang B; Singh S
    Mol Cancer Res; 2018 Feb; 16(2):187-196. PubMed ID: 29117940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ETV4 and AP1 Transcription Factors Form Multivalent Interactions with three Sites on the MED25 Activator-Interacting Domain.
    Currie SL; Doane JJ; Evans KS; Bhachech N; Madison BJ; Lau DKW; McIntosh LP; Skalicky JJ; Clark KA; Graves BJ
    J Mol Biol; 2017 Oct; 429(20):2975-2995. PubMed ID: 28728983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional activation of OCT4 by the ETS transcription factor PEA3 in NCCIT human embryonic carcinoma cells.
    Park SW; Do HJ; Ha WT; Han MH; Park KH; Song H; Kim NH; Kim JH
    FEBS Lett; 2014 Aug; 588(17):3129-36. PubMed ID: 24983502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA 630 Represses NANOG Expression through Transcriptional and Post-Transcriptional Regulation in Human Embryonal Carcinoma Cells.
    Chu WK; Hung LM; Hou CW; Chen JK
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contexts.
    Mesquita D; Barros-Silva JD; Santos J; Skotheim RI; Lothe RA; Paulo P; Teixeira MR
    Oncotarget; 2015 Mar; 6(7):5217-36. PubMed ID: 25595908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic functions of developmental pluripotency associated factor 4 (Dppa4) in pluripotent stem cells and cancer.
    Klein RH; Tung PY; Somanath P; Fehling HJ; Knoepfler PS
    Stem Cell Res; 2018 Aug; 31():83-94. PubMed ID: 30031967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of ETV4 is associated with poor prognosis in prostate cancer: involvement of uPA/uPAR and MMPs.
    Qi M; Liu Z; Shen C; Wang L; Zeng J; Wang C; Li C; Fu W; Sun Y; Han B
    Tumour Biol; 2015 May; 36(5):3565-72. PubMed ID: 25544710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fli-1 promotes proliferation and upregulates NANOGP8 expression in T-lymphocyte leukemia cells.
    Park SW; Do HJ; Choi W; Kim JH
    Biochimie; 2020 Jan; 168():1-9. PubMed ID: 31626853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KLF4 and PBX1 directly regulate NANOG expression in human embryonic stem cells.
    Chan KK; Zhang J; Chia NY; Chan YS; Sim HS; Tan KS; Oh SK; Ng HH; Choo AB
    Stem Cells; 2009 Sep; 27(9):2114-25. PubMed ID: 19522013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foxa1 contributes to the repression of Nanog expression by recruiting Grg3 during the differentiation of pluripotent P19 embryonal carcinoma cells.
    Chen T; He S; Zhang Z; Gao W; Yu L; Tan Y
    Exp Cell Res; 2014 Aug; 326(2):326-35. PubMed ID: 24803390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanog regulates molecules involved in stemness and cell cycle-signaling pathway for maintenance of pluripotency of P19 embryonal carcinoma stem cells.
    Choi SC; Choi JH; Park CY; Ahn CM; Hong SJ; Lim DS
    J Cell Physiol; 2012 Nov; 227(11):3678-92. PubMed ID: 22378194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium arsenite dependent protein expression analysis on human embryonic carcinoma (NCCIT) cell line.
    Das ND; Park JH; Jung KH; Lee HT; Park KS; Choi MR; Chai YG
    Toxicol Lett; 2011 Nov; 207(2):149-58. PubMed ID: 21925251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of acute ethanol treatment on NCCIT cells and NCCIT cell-derived embryoid bodies (EBs).
    Jung KH; Das ND; Park JH; Lee HT; Choi MR; Chung MK; Park KS; Jung MH; Lee BC; Choi IG; Chai YG
    Toxicol In Vitro; 2010 Sep; 24(6):1696-704. PubMed ID: 20621659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.